AzTrials
AzTrials

Psychosomatic MedicineEPPIKNCT05240105

Evaluation of the "Platform Model" for Staffing in Psychiatric and Psychosomatic Clinics

An observational study of Psychosomatic Medicine, run by University Hospital Heidelberg at 1 site in Germany.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study aims to evaluate the so-called platform model and its suitability to determine staffing in hospitals for psychosomatic medicine and psychotherapy. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Psychosomatic Medicine
How many people
5,961 participants
Where
1 siteGermany
Study dates
11 Jun 2021to 31 Dec 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: nationwide German population of psychosomatic specialist clinics and departments at University hospitals, general hospitals, or psychiatric hospitals

Who may be able to join

  • belong to the predefined nationwide population of psychosomatic specialist clinics and departments
  • randomly selected for inclusion in the study,
  • the clinic management (head physician or comparable) agrees to participation in the study
  • possibility of electronic recording of the qualified therapy units for all treating professional groups.
  • patient treated in one of the selected clinics on the corresponding ward or day clinic
  • at least 18 years old

Who cannot join

  • none

Trial locations and contacts

1 site in 1 country.

Germany1 site, 1 recruiting
  • Simone University Jennissen

    Heidelberg, Baden-Wurttemberg, 69120

    Simone U Jennissen, PhD, +4962215634620, simone.jennissen@med.uni-heidelberg.de

    Hans-Christoph Friederich, Prof.

    Recruiting

Other trials in Germany

About this study

Official title: Evaluation of the Suitability of the "Platform Model" as an Instrument for Staffing in Psychiatric and Psychosomatic Clinics (EPPIK) - Subproject Psychosomatics

This study aims to evaluate the so-called platform model and its suitability to determine staffing in hospitals for psychosomatic medicine and psychotherapy.

Read the detailed description

The aim of the study is to test the suitability of a structural model (so-called platform model) developed by a working group of various scientific societies and professional associations for staffing in psychosomatic medicine and psychotherapy. For this purpose, in three steps (1.) the four treatment clusters developed in the platform model will be quantified and empirically validated on the basis of the therapeutic services provided in health care practice; (2.) the current staffing for the four treatment clusters will be described ("as-is analysis"); and (3.) prototypical therapy plans will be developed as a basis for estimating the target staffing requirements. On this basis, a target staffing estimate will be made for all professional groups.

For the study, a total of 80 psychosomatic clinics from Germany will be randomly selected, belonging in equal parts to the groups of psychosomatic university clinics, psychosomatic specialist hospitals, and psychosomatic departments in somatic or in psychiatric hospitals. In addition, 20 day clinics are included. In these clinics, the structural framework conditions including staffing will be surveyed and the routine documentation of therapy units will be evaluated by cluster analysis in order to empirically validate the presumed treatment clusters and to describe the necessary staffing requirements.

The empirical examination and validation of the platform model, including the four assumed treatment clusters, has the potential to positively influence care practice in the long term by adjusting staffing levels in psychosomatic clinics to actual care requirements.

Being tested
no intervention, purely observational

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • no intervention, purely observationalOther

    There will be no interventions. The study is purely observational and investigates differences in naturally occuring treatments at these four types of departments for Psychosomatic Medicine.

Study groups in NCT05240105
Study groupRoleWhat they receive
Departments for Psychosomatic Medicine at University Clinicsno study interventions, observational group
Receives: Other: no intervention, purely observational
Clinics specialized in Psychosomatic Medicineno study interventions, observational group
Receives: Other: no intervention, purely observational
Departments for Psychosomatic Medicine at general hospitalsno study interventions, observational group
Receives: Other: no intervention, purely observational
Departments for Psychosomatic Medicine at psychiatric hospitalsno study interventions, observational group
Receives: Other: no intervention, purely observational

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Administered Treatments

    units of psychotherapeutic treatment administered to each patient by physicians, psychologists, nurses, art therapists, social workers, and physiotherapists

    Measured: Week one of treatment: assessment of administered treatment units

  2. Administered Treatments

    units of psychotherapeutic treatment administered to each patient by physicians, psychologists, nurses, art therapists, social workers, and physiotherapists

    Measured: Week two of treatment: assessment of administered treatment units

  3. Administered Treatments

    units of psychotherapeutic treatment administered to each patient by physicians, psychologists, nurses, art therapists, social workers, and physiotherapists

    Measured: Week three of treatment: assessment of administered treatment units

  4. Administered Treatments

    units of psychotherapeutic treatment administered to each patient by physicians, psychologists, nurses, art therapists, social workers, and physiotherapists

    Measured: Week four of treatment: assessment of administered treatment units

  5. Administered Treatments

    units of psychotherapeutic treatment administered to each patient by physicians, psychologists, nurses, art therapists, social workers, and physiotherapists

    Measured: Week five of treatment: assessment of administered treatment units

  6. Administered Treatments

    units of psychotherapeutic treatment administered to each patient by physicians, psychologists, nurses, art therapists, social workers, and physiotherapists

    Measured: Week six of treatment: assessment of administered treatment units

  7. Administered Treatments

    units of psychotherapeutic treatment administered to each patient by physicians, psychologists, nurses, art therapists, social workers, and physiotherapists

    Measured: Week seven of treatment: assessment of administered treatment units

  8. Administered Treatments

    units of psychotherapeutic treatment administered to each patient by physicians, psychologists, nurses, art therapists, social workers, and physiotherapists

    Measured: Week eight of treatment: assessment of administered treatment units

Secondary outcomes (1)
  1. HONOS - Health of the Nation Outcome Scales

    measure of severity of mental illness

    Measured: administered once per patient at week one of treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Feb 2022
  2. Study start11 Jun 2021
  3. Primary completion31 May 2023 (estimated)
  4. Study completion31 Dec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
5,961 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05240105
Sponsor's protocol ID
EPPIK
Acronym
EPPIK
Status last verified
Feb 2022
First submitted
31 Jan 2022
Last updated
15 Feb 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Psychosomatic Medicine, run by University Hospital Heidelberg at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 15 Feb 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Simone U Jennissen, PhD (004962215634620, simone.jennissen@med.uni-heidelberg.de), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Administered Treatments (time frame: Week one of treatment: assessment of administered treatment units). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Feb 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in